Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Actavis Inc

02 1Sandoz B2B

03 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LOXAPINE HYDROCHLORIDE

Brand Name : LOXITANE IM

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 50MG BASE/ML

Packaging :

Approval Date : 1982-01-01

Application Number : 18039

Regulatory Info : DISCN

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LOXAPINE (LOXAPINE HYDROCHLORIDE)

Brand Name : LOXAPAC IM

Dosage Form : SOLUTION

Dosage Strength : 50MG/ML

Packaging : 1ML

Approval Date :

Application Number : 2169991

Regulatory Info : Prescription

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LOXAPINE HYDROCHLORIDE

Brand Name : LOXITANE C

Dosage Form : CONCENTRATE;ORAL

Dosage Strength : EQ 25MG BASE/ML

Packaging :

Approval Date : 1982-01-01

Application Number : 17658

Regulatory Info : DISCN

Registration Country : USA

blank